Lendalizumab (Anti-Complement C5)
Product Specifications
CAS Number
2210314-30-8
Synonyms
ALXN1007, Olendalizumab
Target
Complement System
Applications
Immunology & Inflammation
Additionnal Information
Lendalizumab (Anti-Complement C5) is a proprietary antibody that targets the complement protein C5a with potential immunomodulating and anti-inflammatory activities. MW : 146.02 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV739761 1.0 µg DNA
PCMTD1P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details LY405510 100 µg
C1orf86 (FAAP20) (NM_182533) Human Over-expression Lysate
Sign In for Pricing
View Details 
MBS9500525-01 1 Kit
Retinoid X Receptor gamma Colorimetric Cell-Based ELISA Kit
Sign In for Pricing
View Details MBS9500525-02 5x 1 Kit
Retinoid X Receptor gamma Colorimetric Cell-Based ELISA Kit
Sign In for Pricing
View Details